Know Cancer

forgot password

Follow-Up Study of Women Evaluated and Treated for Infertility

Not Enrolling
Infertility, Cancer

Thank you

Trial Information

Follow-Up Study of Women Evaluated and Treated for Infertility

BACKGROUND: We previously conducted a retrospective cohort study of 12,193 patients
evaluated for infertility between 1960-1988 at five clinical sites. Detailed information
abstracted from the medical records, along with questionnaires administered to located
patients and cancer incidence and mortality data derived from cancer registries and the
National Death Index, allowed us to examine cancer risk related to different causes of
infertility and treatments while controlling for other patient characteristics. Although
there were some increases of certain cancers related to various causes of infertility, we
generally did not observe substantial relationships related to use of different fertility
drugs. The one exception was some increased risk of uterine cancers with clomiphene use, of
interest given the drug's chemical similarity to tamoxifen. Our numbers of patients with
certain cancers (e.g., ovarian, uterine) were, however, limited and we had insufficient
power to evaluate subgroup effects (e.g., drug relationships among nulligravid women).

OBJECTIVES: We are therefore proposing an updated follow-up of these patients in order to
assess cancer risk in relation to causes of infertility and therapeutic regimens used to
treat these causes.

ELIGIBILITY: This study will attempt to gain an additional 10 years of follow-up among the
patients deemed eligible for the previous investigation. This includes women with both
primary and second infertility. Approximately 39% of the cohort previously were prescribed
clomiphene citrate, while 10% received gonadotrophins.

DESIGN: Passive follow-up will be attempted for patients who previously did not participate
and for whom only information available in clinic records could be retained. All other
patients will be traced for active as well as passive follow-up. Active follow-up will
involve requesting that patients complete a short questionnaire, whereas passive follow-up
will be via linkage to cancer registries and the National Death Index. While cancer risks
will be assessed in relation to the general population, the majority of comparisons will be
internal ones, involving the calculation of relative risks (RRs) associated with different
causes of infertility or treatment regimens while controlling for other cancer risk

Inclusion Criteria


The following criteria for inclusion in the study cohort will apply:

Patient is female.

Patient was evaluated for infertility between (and including) 1965 and 1988.

Patient had a U.S. address at the time of evaluation for infertility.

Patient was seen twice by the physician, or was seen once but had a referral from another

Patient's infertility was not due to gonadal dysgenesis or congenital abnormalities of the
reproductive system.

Patient's visit to the infertility specialist was not to have a tubal ligation reversed.

Type of Study:


Study Design:


Principal Investigator

Louise Brinton, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)


United States: Federal Government

Study ID:




Start Date:

June 1996

Completion Date:

Related Keywords:

  • Infertility
  • Cancer
  • Clomid
  • Breast Cancer
  • Ovarian Cancer
  • Ovulation Induction
  • Pergonal
  • Infertility



Wayne State University Hutzel Hospital Detroit, Michigan  48201
Columbia University New York, New York  10032-3784
Stanford Medical Center Stanford, California  94303
University of Illinois Chicago, Illinois  60612